Skip to content

Clinical trials

Completed Phase 2 Spasm trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Spasm Phase: Phase 2 Status: Completed Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20071
20102
20122
20131
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Dalhousie University1
Enzymotec1
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.1
National Institute of Neurological Disorders and Stroke (NINDS)1
Neurana Pharmaceuticals, Inc.1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Raymond Foster1
Tel-Aviv Sourasky Medical Center1
University of British Columbia1
Yolanda de Diego Otero1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Spasm10
Attention Deficit Disorder with Hyperactivity5
Anxiety Disorders2
Acute Pain1
Autism Spectrum Disorder1
Autistic Disorder1
Back Pain1
Blepharospasm1
Dystonia1
Dystonic Disorders1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.